You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Complete Cystectomy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle

Recruiting
  • Muscle Invasive Bladder Carcinoma
  • +2 more
  • Lymphadenectomy
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 9, 2023

Muscle Invasive Bladder Cancer, Urothelial Carcinoma Trial in Tianjin (Tislelizumab, Nab paclitaxel)

Active, not recruiting
  • Muscle Invasive Bladder Cancer
  • Urothelial Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Nov 23, 2022

Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma, Stage I Prostate Cancer Trial in Los Angeles (other,

Terminated
  • Infiltrating Bladder Urothelial Carcinoma
  • +9 more
  • Cytology Specimen Collection Procedure
  • +4 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 15, 2021

Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8, Muscle Invasive Bladder Carcinoma Trial in Seattle (drug,

Recruiting
  • Stage II Bladder Cancer AJCC v8
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)

Not yet recruiting
  • Neuroendocrine Carcinoma of the Bladder
  • Bladder Cancer
  • (no location specified)
Oct 14, 2023

Bladder Cancer Trial in Washington, Baltimore (Prostate capsule-sparing radical cystectomy, Nerve sparing radical cystectomy)

Not yet recruiting
  • Bladder Cancer
  • Prostate capsule-sparing radical cystectomy
  • Nerve sparing radical cystectomy
  • Washington, District of Columbia
  • +1 more
Mar 28, 2023

Negative Surgical Margins Trial (Prostate and seminal-sparing Cystectomy, Conventional Radical Cystoprostatectomy)

Not yet recruiting
  • Negative Surgical Margins
  • Prostate and seminal-sparing Cystectomy
  • Conventional Radical Cystoprostatectomy
  • (no location specified)
May 30, 2023

Stage 0is Bladder Urothelial Carcinoma, Stage I Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma Trial in Los

Terminated
  • Stage 0is Bladder Urothelial Carcinoma
  • +3 more
  • Questionnaire Administration
  • Radical Cystectomy
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
May 1, 2019

Muscle Invasive Bladder Cancer Urothelial Carcinoma Trial in Tianjin (Tislelizumab Nab paclitaxel)

Recruiting
  • Muscle Invasive Bladder Cancer Urothelial Carcinoma
  • Tislelizumab Nab paclitaxel
  • Tianjin, Tianjin, China
    ianjin Medical University Second Hospital
Jun 8, 2022

Bladder Cancer Trial in United States (Nivolumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Bladder Cancer
  • Duarte, California
  • +6 more
Jul 7, 2022

Bladder Cancer, Adult Solid Tumor Trial in Milano, Roma, Torino (Nivolumab, Visugromab (CTL-002), Placebo)

Recruiting
  • Bladder Cancer
  • Adult Solid Tumor
  • Milano, Italy
  • +3 more
Sep 21, 2023

Bladder Cancer, Radical Cystectomy Trial (Preop Intervention and Monitored Recovery, Usual Care)

Not yet recruiting
  • Bladder Cancer
  • Radical Cystectomy
  • Preop Intervention and Monitored Recovery
  • Usual Care
  • (no location specified)
Jan 26, 2023

Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

Recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jun 27, 2022

Urinary Bladder Cancer Trial in München, Ulm, Würzburg (drug, radiation, procedure)

Active, not recruiting
  • Urinary Bladder Cancer
  • München, Germany
  • +2 more
Oct 19, 2022

Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)

Not yet recruiting
  • Non-Muscle Invasive Bladder Cancer
  • HER2
  • (no location specified)
Jul 16, 2023

Muscle-Invasive Bladder Carcinoma, Chemo Effect, Surgery Trial in Rome (cisplatin based neoadjuvant chemo, Radical cystectomy

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • +2 more
  • cisplatin based neoadjuvant chemotherapy
  • Radical cystectomy alone
  • Rome, Italy
    Riccardo Mastroianni
Mar 8, 2023

Bladder Cancer Trial in Chapel Hill, Durham (pembrolizumab, gemcitabine and cisplatin)

Active, not recruiting
Has Results
  • Bladder Cancer
  • pembrolizumab, gemcitabine and cisplatin
  • Chapel Hill, North Carolina
  • +1 more
Oct 11, 2022

Sexual Function in Women UndergoingRadical Cystectomy for

Recruiting
  • Bladder Carcinoma
  • Survey Administration
  • Washington, District of Columbia
  • +12 more
May 26, 2022

Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

Not yet recruiting
  • Urothelial Carcinoma Bladder
  • Androgen Receptor Positive
  • Providence, Rhode Island
    Lifespan Cancer Institute
May 1, 2023

Bladder Carcinoma, Refractory Bladder Carcinoma, Urinary Tract Infection Trial in Buffalo (Clindamycin, Diary, Ertapenem)

Recruiting
  • Bladder Carcinoma
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 3, 2022

Gender Related Coping and Survivorship for Genitourinary Cancers

Recruiting
  • Bladder Cancer
  • Additional Education
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jan 23, 2023

Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)

Not yet recruiting
  • Urothelial Bladder Carcinoma
  • Sacituzumab govitecan
  • +2 more
  • Santiago De Compostela, A Coruña, Spain
  • +9 more
Nov 14, 2023

Bladder Cancer Trial in Chapel Hill, Philadelphia (Pembrolizumab, Entinostat)

Recruiting
  • Bladder Cancer
  • Chapel Hill, North Carolina
  • +1 more
Oct 10, 2022

Bladder Cancer Trial in United States (Cabozantinib, Atezolizumab, Cystectomy)

Recruiting
  • Bladder Cancer
  • Hackensack, New Jersey
  • +4 more
Aug 26, 2022

Urothelial Carcinoma Trial in France, Italy, United States (retifanlimab, epacadostat, INCAGN02385)

Recruiting
  • Urothelial Carcinoma
  • Iowa City, Iowa
  • +11 more
Dec 1, 2022